Truepoint Inc’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $270K | Buy |
2,099
+147
| +8% | +$17.2K | 0.01% | 137 |
|
|
2026
Q1 | $235K | Buy |
+1,952
| New | +$225K | 0.01% | 140 |
|
|
2024
Q1 | – | Sell |
-8,106
| Closed | -$884K | – | 201 |
|
|
2023
Q4 | $884K | Buy |
8,106
+1,408
| +21% | +$146K | 0.03% | 85 |
|
|
2023
Q3 | $690K | Buy |
6,698
+1,290
| +24% | +$139K | 0.02% | 99 |
|
|
2023
Q2 | $624K | Buy |
5,408
+26
| +0.5% | +$2.95K | 0.02% | 90 |
|
|
2023
Q1 | $573K | Buy |
5,382
+7
| +0.1% | +$756 | 0.02% | 87 |
|
|
2022
Q4 | $596K | Sell |
5,375
-22
| -0.4% | -$2.25K | 0.02% | 87 |
|
|
2022
Q3 | $465K | Sell |
5,397
-446
| -8% | -$39.8K | 0.02% | 87 |
|
|
2022
Q2 | $533K | Sell |
5,843
-165
| -3% | -$14.6K | 0.03% | 92 |
|
|
2022
Q1 | $493K | Buy |
6,008
+9
| +0.2% | +$710 | 0.02% | 89 |
|
|
2021
Q4 | $460K | Buy |
5,999
+1,810
| +43% | +$144K | 0.02% | 91 |
|
|
2021
Q3 | $315K | Sell |
4,189
-466
| -10% | -$35.4K | 0.02% | 109 |
|
|
2021
Q2 | $362K | Buy |
4,655
+571
| +14% | +$42.5K | 0.02% | 95 |
|
|
2021
Q1 | $300K | Buy |
4,084
+7
| +0.2% | +$516 | 0.02% | 97 |
|
|
2020
Q4 | $318K | Buy |
+4,077
| New | +$312K | 0.02% | 94 |
|
|
2020
Q1 | – | Sell |
-4,779
| Closed | -$415K | – | 84 |
|
|
2019
Q4 | $415K | Buy |
4,779
+163
| +4% | +$13.4K | 0.03% | 76 |
|
|
2019
Q3 | $371K | Buy |
4,616
+6
| +0.1% | +$481 | 0.03% | 75 |
|
|
2019
Q2 | $369K | Sell |
4,610
-1,533
| -25% | -$117K | 0.03% | 83 |
|
|
2019
Q1 | $488K | Buy |
6,143
+1,208
| +24% | +$90.3K | 0.04% | 63 |
|
|
2018
Q4 | $360K | Sell |
4,935
-1,506
| -23% | -$106K | 0.03% | 74 |
|
|
2018
Q3 | $436K | Sell |
6,441
-2,131
| -25% | -$136K | 0.04% | 71 |
|
|
2018
Q2 | $496K | Buy |
8,572
+8,116
| +1,780% | +$458K | 0.04% | 62 |
|
|
2018
Q1 | $7.99K | Sell |
456
-4,962
| -92% | -$268K | 0.06% | 46 |
|
|
2017
Q4 | $291K | Buy |
5,418
+1,290
| +31% | +$71.5K | 0.03% | 77 |
|
|
2017
Q3 | $252K | Sell |
4,128
-296
| -7% | -$17.9K | 0.02% | 86 |
|
|
2017
Q2 | $268K | Buy |
4,424
+6
| +0.1% | +$365 | 0.03% | 87 |
|
|
2017
Q1 | $268K | Buy |
4,418
+5
| +0.1% | +$303 | 0.03% | 79 |
|
|
2016
Q4 | $271K | Buy |
+4,413
| New | +$258K | 0.03% | 74 |
|
Other funds holding MRK
Truepoint Inc's MRK Position: Q2 2026 in Review
Truepoint Inc increased its Merck (MRK) stake by 7.5% in Q2 2026, buying an estimated $17.2K and bringing the position to 2,099 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #137.
Truepoint Inc first reported a position in MRK in Q4 2016 and has held it in 28 quarters since. The position peaked at $884K in Q4 2023. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Truepoint Inc held 2,099 shares of Merck worth $270K as of Q2 2026.
- Truepoint Inc bought 147 Merck shares in Q2 2026, an estimated $17.2K.
- Merck made up 0.01% of Truepoint Inc's portfolio in Q2 2026, its #137 holding.
- Truepoint Inc first reported a position in Merck in Q4 2016 and has held it in 28 quarters since.
- Truepoint Inc's Merck position peaked at $884K in Q4 2023.
- 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Truepoint Inc's 13F filing for Q2 2026, filed 31 Jul 2026.